Confounding effect of blood volume and body mass index on blood neurofilament light chain levels

Confounding effect of blood volume and body mass index on blood neurofilament light chain levels

Abstract Blood Neurofilament light chain (NfL) has been suggested as a promising biomarker in several neurological conditions. Since blood NfL is the consequence of leaked NfL from the cerebrospinal fluid, differences in individuals’ Body Mass Index (BMI) or blood volume (BV) might affect its correl...

Full description

Bibliographic Details
Main Authors:	Ali Manouchehrinia, Fredrik Piehl, Jan Hillert, Jens Kuhle, Lars Alfredsson, Tomas Olsson, Ingrid Kockum
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.50972

Similar Items

Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
by: Antoinette Depoorter, et al.
Published: (2018-11-01)

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
by: Johanna Gaiottino, et al.
Published: (2013-01-01)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
by: Simon Thebault, et al.
Published: (2020-11-01)

Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis
by: Ali Manouchehrinia, et al.
Published: (2018-05-01)

Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis
by: Ngoc Dung Le, et al.
Published: (2020-10-01)

Blood neurofilament light as a potential endpoint in Phase 2 studies in MS
by: Maria Pia Sormani, et al.
Published: (2019-06-01)

Ratio and index of Neurofilament light chain indicate its origin in Guillain‐Barré Syndrome
by: Peter Körtvelyessy, et al.
Published: (2020-11-01)

The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis.
by: Ellen Iacobaeus, et al.
Published: (2011-05-01)

Renal function is associated with blood neurofilament light chain level in older adults
by: Shoshin Akamine, et al.
Published: (2020-11-01)

The proteome of neurofilament-containing protein aggregates in blood
by: Rocco Adiutori, et al.
Published: (2018-07-01)

Alcohol Consumption and Risk of Common Autoimmune Inflammatory Diseases—Evidence From a Large-Scale Genetic Analysis Totaling 1 Million Individuals
by: Xia Jiang, et al.
Published: (2021-06-01)

Predictive value of serum neurofilament light chain for persistent cognitive deficits in elderly depressive patients
by: Christoph Linnemann, et al.
Published: (2021-04-01)

Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis
by: Sarah Fidler, et al.
Published: (2021-05-01)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
by: Andre Strydom, et al.
Published: (2018-04-01)

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
by: Carlo Wilke, et al.
Published: (2020-07-01)

The DQB1*03:02 Genotype and Treatment for Pain in People With and Without Multiple Sclerosis
by: Sarah Burkill, et al.
Published: (2020-09-01)

Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
by: Marco Duering, et al.
Published: (2018-05-01)

Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease
by: Nils Peters, et al.
Published: (2020-09-01)

Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature
by: Delia Gagliardi, et al.
Published: (2019-08-01)

The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis
by: Ulrika Birkeldh, et al.
Published: (2017-12-01)

Neurofilament light in blood – What more is needed for clinical implementation in multiple sclerosis?
by: Henrik Zetterberg
Published: (2020-07-01)

Role of Blood Neurofilaments in the Prognosis of Amyotrophic Lateral Sclerosis: A Meta-Analysis
by: Yan-ni Zhou, et al.
Published: (2021-10-01)

Author Correction: The potential of neurofilaments analysis using dry-blood and plasma spots
by: Vittoria Lombardi, et al.
Published: (2020-06-01)

Cerebrospinal Fluid and Blood Neurofilament Light Chain Protein in Prion Disease and Other Rapidly Progressive Dementias: Current State of the Art
by: Samir Abu-Rumeileh, et al.
Published: (2021-03-01)

Neurofilament light chain in the vitreous humor of the eye
by: Manju L. Subramanian, et al.
Published: (2020-09-01)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
by: Carolina Ferreira-Atuesta, et al.
Published: (2021-04-01)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
by: Dániel Pukoli, et al.
Published: (2021-05-01)

CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis
by: Marc Pawlitzki, et al.
Published: (2019-06-01)

Serum Neurofilament Levels in Children With Febrile Seizures and in Controls
by: Katrina S. Evers, et al.
Published: (2020-09-01)

Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep.
by: Henrik Zetterberg, et al.
Published: (2019-01-01)

High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk
by: Anna Karin Hedström, et al.
Published: (2020-01-01)

Neurofilament Light Chain as A Biomarker for Brain Metastases
by: Anne Winther-Larsen, et al.
Published: (2020-10-01)

Neurofilament light chain in the assessment of patients with multiple sclerosis
by: Renan Barros DOMINGUES, et al.

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
by: Kristin N. Varhaug, et al.
Published: (2019-04-01)

Structure and regulation of the human neurofilament light chain gene
by: Yazdanbakhsh, Karina
Published: (1990)

Neurofilament Light Chain (NfL) in Blood—A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke
by: Milos Pekny, et al.
Published: (2021-06-01)

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
by: Dejan Jakimovski, et al.
Published: (2019-09-01)

Heterogeneity in white blood cells has potential to confound DNA methylation measurements.
by: Bjorn T Adalsteinsson, et al.
Published: (2012-01-01)

Smoking and Epstein–Barr virus infection in multiple sclerosis development
by: Anna Karin Hedström, et al.
Published: (2020-07-01)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
by: Tomohiro Hayashi, et al.
Published: (2021-05-01)